Kevin Patrick O'Hara, an affiliate of HealthStream, Inc., filed a Form 144 notice on November 5, 2026, proposing the sale of 4,000 shares of HealthStream common stock through J.P. Morgan Securities LLC on NASDAQ.
Michael M. Collier, an officer of HealthStream, Inc., filed a Form 144 notice on November 5, 2026, disclosing a proposed sale of 21,300 shares of HealthStream common stock with an aggregate market value of $640,000.00.
HealthStream, Inc. filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the three and nine months ended September 30, 2026, disclosing revenue growth, a common stock issuance, and updated balance sheet figures.
HealthStream, Inc. director Deborah Taylor Tate filed a Form 144 notice on November 5, 2026, disclosing a proposed sale of 3,281 shares of HealthStream common stock with an aggregate market value of $106,000.00.
HealthStream, Inc. officer Scott A. Roberts filed a Form 144 notice on November 5, 2026, disclosing a proposed sale of 9,500 shares of HealthStream common stock through Raymond James & Associates, Inc.
DENTSPLY SIRONA Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 5, 2026, reporting third-quarter net sales of $836 million and a net loss attributable to the company of $2 million.
Kimball Electronics, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 5, 2026, reporting first-quarter results that included a significant decline in net income and a $100.9 million acquisition.
ICF International, Inc. filed an 8-K on November 5, 2026, announcing financial results for its second fiscal quarter ended September 30, 2026, and reporting that its Board of Directors declared a quarterly cash dividend of $0.14 per share.
VSE Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 5, 2026, reporting a significant expansion of its balance sheet following acquisition activity.
The Chemours Company (NYSE:CC) filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 5, 2026, reporting third-quarter net income of $196 million and nine-month net sales of $4,512 million.